Services-Home Health Care Services
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, including CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.
Discounted Cash Flow Valuation of Adapthealth Corp.
Growth
%
%
Discount
%
%
Multiple
g\r | +10% | +11% | +12% | +13% | +14% |
---|---|---|---|---|---|
0% | 10 | 9 | 8 | 8 | 7 |
+1% | 11 | 10 | 9 | 8 | 8 |
+2% | 13 | 11 | 10 | 9 | 8 |
+3% | 14 | 13 | 11 | 10 | 9 |
+4% | 17 | 14 | 12 | 11 | 10 |
Years | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | TV |
---|---|---|---|---|---|---|---|---|---|---|---|---|
FCF | $53.22M | $43.39M | $35.38M | $28.84M | $23.51M | $19.17M | $15.63M | $12.74M | $10.39M | $8.471M | $6.906M | $69.06M |
DCF | $37.73M | $26.75M | $18.96M | $13.44M | $9.532M | $6.758M | $4.791M | $3.396M | $2.408M | $1.707M | $17.07M | |
Value | $142.6M |
In the chart Earnings are multiplied by this value.
High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.
Years | 12-2017 | 12-2018 | 12-2019 | 12-2020 | 12-2021 | 12-2022 | 12-2023 | TTM |
---|---|---|---|---|---|---|---|---|
Net Margin | - | 0.6% | -3.2% | -6.1% | 5.8% | 2.1% | -21% | -21% |
ROA | -0.22% | 1.1% | 5.4% | 3.9% | 4.3% | 3.6% | -13% | -13% |
ROE | -2.9% | 1.8% | 120% | -15% | 6.9% | 2.9% | -46% | -47% |
The average Net Margin over the past 5 years is -3.67%.
The trend of Net Margin over the past 5 years is -2.32%.
The average ROA over the past 5 years is +0.87%.
The trend of ROA over the past 5 years is -2.2%.
The average ROE over the past 5 years is +11.24%.
The trend of ROE over the past 5 years is -16.06%.
Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.
Years | 12-2017 | 12-2018 | 12-2019 | 12-2020 | 12-2021 | 12-2022 | 12-2023 | TTM | ||
---|---|---|---|---|---|---|---|---|---|---|
Debt FCF | - | - | 10.37 | 5.17 | 31.16 | -128.16 | 15.53 | 42.07 | ||
Debt Equity | - | 1.25 | -27.91 | 1.93 | 1.09 | 1.04 | 1.52 | 1.52 | ||
MIN | ||||||||||
Graham Stability | - | - | - | - | - | 100% | -1.4K% | -1.4K% |
The Debt/FCF trailing twelve month is 42.07.
The trend of Debt/FCF over the past 5 years is -12.30.
Graham’s Stability measure stands at -14.47.
Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.
Years | 12-2018 | 12-2020 | 12-2022 | Trend |
---|---|---|---|---|
Revenue | 56% | 45% | 7.7% | -17% |
Net Income | - | - | - | - |
Stockholders Equity | 67% | 52% | -32% | -100K% |
FCF | - | -2.8% | - | -350% |
The Revenue CAGR over the past 5 years is +56.1%.
The trend of Revenue growth rate over the past 5 years is -16.98%.
The Earnings CAGR over the past 5 years is -.
The trend of Earnings growth rate over the past 5 years is -.
The Equity CAGR over the past 5 years is +66.89%.
The trend of Equity growth rate over the past 5 years is -99.84K%.
The FCF CAGR over the past 5 years is -.
The trend of FCF growth rate over the past 5 years is -352.38%.